Cek Fakta: Tidak Benar Jepang Sarankan Penggunaan Ivermectin untuk Obat Covid-19

·Bacaan 2 menit

Liputan6.com, Jakarta - Kabar tentang Jepang menyarankan menggunakan ivermectin sebagai obat melawan virus corona Covid-19 beredar di media sosial. Kabar tersebut disebarkan oleh salah satu akun Facebook pada 6 September 2021.

Akun Facebook tersebut menuliskan narasi bahwa pemerintah Jepang telah mengambil keputusan menggunakan ivermectin untuk pengobatan Covid-19.

Berikut narasinya:

BREAKING: Japanese medical association chairman tells doctors to prescribe Ivermectin for COVID

"...four pills should be distributed to everyone in the country, so that people can take them “as soon as you are infected.”~ Dr. Kazuhiro Nagao

The chairman of the Tokyo Medical Association, Haruo Ozaki, held a press conference this week announcing that the anti-parasite medicine Ivermectin seems to be effective at stopping COVID-19 and publicly recommending that all doctors in Japan immediately begin using Ivermectin to treat COVID.

Ivermectin has been a source of controversy amongst medical professionals regarding the possibility of therapeutic treatments for those diagnosed with COVID-19.

Multiple reports and studies have shown evidence that Ivermectin is effective in combatting illness associated with COVID-19, and in some countries, like India, it is recommended for use even though the World Health Organization does not recommend it.

Dr. Ozaki cited evidence from African nations that have utilized Ivermectin during the pandemic. He stated: “In Africa, if we compare countries distributing Ivermectin once a year with countries who do not give Ivermectin… they don’t give Ivermectin to prevent COVID but to prevent parasitic disease… if we look at COVID numbers in countries that give Ivermectin, the number of cases is 134.4/100,000 and the number of deaths is 2.2/100,000.”

In 2019, Japan’s death rate from influenza amounted to 2.9 death cases per 100,000 inhabitants.

The Tokyo Medical Association chairman compared statistics from African countries that did use Ivermectin yearly with those that did not: “Now African countries which do not distribute Ivermectin: 950.6 cases per 100,000 and 29.3 deaths per 100,000.”

In his opinion, he believes that this shows a clear difference between the illness and fatality rates amongst nations that use Ivermectin and those that do not: “I believe the difference is clear. Of course one cannot conclude that Ivermectin is effective only on the basis of these figures, but when we have all of these elements, we cannot say that Ivermectin is absolutely not effective, at least not me.”

He added that, given the situation, other studies can be done to “confirm its efficacy,” insinuating that it is worth using as a treatment, given that in his estimation, Japan is “in a crisis situation.”

He said, “I think we are in a situation where we can afford to give [patients] this treatment.”

Another prominent Japanese physician, Dr. Kazuhiro Nagao, appeared on Japanese television proposing that COVID-19 should be treated as a Class 5 illness as opposed to its current classification as a Class 2. In Japan, illnesses are categorized by a classification system; approaching COVID as a Class 5 illness would mean that it could be treated like a seasonal flu.Dr. Nagao said he has used Ivermectin as an early treatment for over 500 COVID patients with practically a 100% success rate, and that it should be used nationwide.

About the effectiveness of Ivermectin in treating COVID patients, he said: “It starts being effective the very next day… My patients can reach me by message 24/7 and they tell me they feel better the next day.”

Nagao was asked by the TV anchor when patients should take Ivermectin if diagnosed with COVID-19. He replied: “The same day, I mean if you are infected today, you take it today… It is a medication that should be given for mildly ill patients. If you give it to hospital patients, it’s too late. This is also the case for the majority of drugs… So you have to give Ivermectin. I am asking our Prime Minister Suga to distribute this drug ‘made in Japan’ on a large scale in the country.”

He added that four pills should be distributed to everyone in the country, so that people can take them “as soon as you are infected.”

Ivermectin originates from a single microbe unearthed from soil in Japan, and in recent years has been called a “wonder” drug that continues to surprise and exceed expectations. It has shown “unexpected” potential as an antibacterial, antiviral and anti-cancer agent, according to a 2017 article from The Journal of Antibiotics.

The same article stated: “Ivermectin has also been demonstrated to be a potent broad-spectrum specific inhibitor of importin ?/?-mediated nuclear transport and demonstrates antiviral activity against several RNA viruses by blocking the nuclear trafficking of viral proteins.”

Benarkah Jepang menyarankan penggunaan ivermectin untuk pengobatan Covid-19? Berikut penelusurannya.

*** Untuk mengetahui kebenaran informasi yang beredar, silakan WhatsApp ke nomor 0811 9787 670 hanya dengan ketik kata kunci yang diinginkan.

Penelusuran Fakta

Cek Fakta Liputan6.com menelusuri kabar tentang Jepang menyarankan menggunakan ivermectin sebagai obat melawan virus corona Covid-19. Penelusuran dilakukan dengan memasukkan kata kunci "japan ivermectin" di kolom pencarian Google Search.

Hasilnya terdapat beberapa artikel yang membantah kabar tersebut. Satu di antaranya artikel berjudul "Japan has not endorsed ivermectin as Covid-19 treatment" yang dimuat situs factcheck.afp.com pada 8 September 2021.

Dalam artikel tersebut dijelaskan bahwa Jepang menyarankan penggunaan obat antiparasit ivermectin untuk mengobati Covid-19, mengutip pernyataan ketua Asosiasi Medis Tokyo, dr Haruo Ozaki adalah klaim yang menyesatkan.

Sedangkan Asosiasi Medis Tokyo tidak mewakili pemerintahan Jepang. Ozaki mengatakan bahwa pihaknya masih melakukan penelitan terhadap kemanjuran ivermectin untuk menyembuhkan Covid-19.

"Kami dapat melakukan penelitian lain untuk memastikan kemanjurannya, tetapi kami berada dalam situasi krisis. Sehubungan dengan penggunaan ivermectin, jelas diperlukan untuk mendapatkan persetujuan dari pasien, dan saya pikir kami berada dalam situasi di mana kami mampu memberi mereka perawatan ini," kata Ozaki.

Sebuah studi klinis oleh Universitas Kitasato Jepang tentang ivermectin sebagai pengobatan Covid-19 sedang berlangsung, tetapi lembaga penyiaran publik NHK melaporkan pada 23 Agustus 2021 bahwa mereka berjuang untuk merekrut peserta.

Referensi:

https://factcheck.afp.com/http%253A%252F%252Fdoc.afp.com%252F9M48JR-1

Kesimpulan

Kabar tentang Jepang menyarankan penggunaan ivermectin untuk obat Covid-19 ternyata tidak benar. Faktanya, Jepang belum memberikan pernyataan resmi terkait rekomendasi ivermectin untuk pengobatan Covid-19.

Banner Cek Fakta: Salah (Liputan6.com/Triyasni)
Banner Cek Fakta: Salah (Liputan6.com/Triyasni)

Tentang Cek Fakta Liputan6.com

Melawan hoaks sama saja melawan pembodohan. Itu yang mendasari kami membuat Kanal Cek Fakta Liputan6.com pada 2018 dan hingga kini aktif memberikan literasi media pada masyarakat luas.

Sejak 2 Juli 2018, Cek Fakta Liputan6.com bergabung dalam International Fact Checking Network (IFCN) dan menjadi patner Facebook. Kami juga bagian dari inisiatif cekfakta.com. Kerja sama dengan pihak manapun, tak akan mempengaruhi independensi kami.

Jika Anda memiliki informasi seputar hoaks yang ingin kami telusuri dan verifikasi, silahkan menyampaikan di email cekfakta.liputan6@kly.id.

Ingin lebih cepat mendapat jawaban? Hubungi Chatbot WhatsApp Liputan6 Cek Fakta di 0811-9787-670 atau klik tautan berikut ini.

Tujuan kami adalah menciptakan tempat yang aman dan menarik bagi pengguna untuk terhubung melalui minat dan kegemaran. Untuk meningkatkan pengalaman komunitas, kami menangguhkan sementara fitur komentar artikel